Roxithromycin API Powder is a semi-synthetic macrolide antibiotic used to treat respiratory tract infections, skin infections, and soft tissue infections by inhibiting bacterial protein synthesis.
It offers a broad spectrum of activity against Gram-positive and some Gram-negative bacteria, with improved oral bioavailability.
Manufactured to strict quality standards, it ensures high purity, efficacy, and safety for pharmaceutical formulations.